Walvax Expands Rights to Notitia’s Gut Microbiota Therapy in Greater China
Walvax Biotechnology Co., Ltd (SHE: 300142), a Chinese biopharmaceutical company, has announced that an amendment...
Notitia Biotechnologies
Walvax Biotechnology Secures Exclusive Rights to Notitia’s Gut Microbiota Therapy
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) announced an exclusive sublicense agreement with US-based Notitia...